SLC2A3 and breast carcinoma: Krzeslak et al. examined GLUT1 and GLUT3 protein expression in breast cancer tissue using Western blot, which reported the presence of GLUT1 in 48.7% and GLUT3 in 22.8% of tumour samples [102].